The Long Run with Luke Timmerman podcast

Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases

03/03/2026

The Long Run with Luke Timmerman

0:00

1:05:45

Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.

D'autres épisodes de "The Long Run with Luke Timmerman"

Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
03/03/2026
1:05:45
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery
17/02/2026
1:08:54
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery by Timmerman Report
Ne ratez aucun épisode de “The Long Run with Luke Timmerman” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.
Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
22/01/2026
1:05:10
Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.
Ep192: Kate Haviland on Following the Science to Precision Immunology
08/01/2026
1:26:06
Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
15/12/2025
1:07:34
Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
Ep190: Neil Kumar on Building a Rare Disease Drug Company
20/11/2025
1:13:12
Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI
12/11/2025
1:12:33
Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.
Ep188: Art Krieg on Innate Immune System Activators for Cancer
28/10/2025
1:09:05
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
Ep187: Eric Fischer on Creating a New Class of Medicines
14/10/2025
1:05:48
Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.
Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope
29/09/2025
1:02:33
Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.

Plus d'épisodes

Découvrez le meilleur des podcasts sur l'application GetPodcast.

Abonnez-vous à tous vos podcasts préférés, écoutez les épisodes sans connexion internet et recevez des recommandations de podcasts passionnants.

Une entreprise de

Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases

The Long Run with Luke Timmerman

D'autres épisodes de "The Long Run with Luke Timmerman"

Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases

Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery

Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

Ep192: Kate Haviland on Following the Science to Precision Immunology

Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

Ep190: Neil Kumar on Building a Rare Disease Drug Company

Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

Ep188: Art Krieg on Innate Immune System Activators for Cancer

Ep187: Eric Fischer on Creating a New Class of Medicines

Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope